| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 8.050 | 21.466 | 9.459 | 36.673 | 48.958 | 8.076 | - |
| Total Income - EUR | - | - | - | 8.050 | 21.466 | 9.459 | 36.673 | 48.958 | 8.076 | - |
| Total Expenses - EUR | - | - | - | 5.061 | 9.330 | 8.321 | 19.427 | 24.487 | 18.784 | - |
| Gross Profit/Loss - EUR | - | - | - | 2.989 | 12.136 | 1.138 | 17.246 | 24.471 | -10.708 | - |
| Net Profit/Loss - EUR | - | - | - | 2.747 | 11.492 | 854 | 16.146 | 23.729 | -10.789 | - |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Mta Accord Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | - | - | 3.875 | 25.232 | 22.571 | 40.961 | 66.136 | 47.122 | - |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | - | - | - | 0 | 1.850 | 21.340 | 38.460 | 38.579 | 38.462 | - |
| Cash | - | - | - | 3.875 | 23.382 | 1.231 | 2.501 | 27.557 | 8.660 | - |
| Shareholders Funds | - | - | - | 2.790 | 14.228 | 14.951 | 30.765 | 54.589 | 43.635 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 1.085 | 11.005 | 7.620 | 10.196 | 11.546 | 3.487 | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4613 - 4613" | |||||||||
| CAEN Financial Year |
4613
|
|||||||||
Comments - Mta Accord Intermed S.r.l.